95 Efficacy, damage accrual and predictors of response to belimumab in active sle patients: a large italian multicenter prospective study

M Larosa; L Iaccarino; M Zen; M Gatto; L Emmi; F Conti; M Mosca; P.L Meroni; M Govoni; S De Vita; R De Angelis; C Salvarani; R Gerli; A Tincani; A Doria

doi:10.1136/lupus-2017-000215.95

Article info

Poster Session

New therapies and therapeutic targets – SLE

95 Efficacy, damage accrual and predictors of response to belimumab in active sle patients: a large italian multicenter prospective study

Free

Authors

M Larosa 1Università degli Studi di Padova – Azienda Ospedaliera, Department of Medicine-DIMED- Division of Rheumatology, Padova, Italy PubMed articles Google scholar articles
L Iaccarino 1Università degli Studi di Padova – Azienda Ospedaliera, Department of Medicine-DIMED- Division of Rheumatology, Padova, Italy PubMed articles Google scholar articles
M Zen 1Università degli Studi di Padova – Azienda Ospedaliera, Department of Medicine-DIMED- Division of Rheumatology, Padova, Italy PubMed articles Google scholar articles
M Gatto 1Università degli Studi di Padova – Azienda Ospedaliera, Department of Medicine-DIMED- Division of Rheumatology, Padova, Italy PubMed articles Google scholar articles
L Emmi 2University of Florence, Interdisciplinary Internal Medicine- Centre for Autoimmune Systemic Diseases- Behçet Centre and Lupus Clinic, Florence, Italy PubMed articles Google scholar articles
F Conti 3Sapienza University, Rheumatology Unit- Department of Internal Medicine and Medical Specialities, Rome, Italy PubMed articles Google scholar articles
M Mosca 4University of Pisa, Department of Clinical and Experimental Medicine- Rheumatology Unit, Pisa, Italy PubMed articles Google scholar articles
P.L Meroni 5IRCCS Istituto- Auxologico Italiano, Experimental Laboratory of Immunological and Rheumatologic Researches, Milan, Italy PubMed articles Google scholar articles
M Govoni 6University of Ferrara, Rheumatology Unit- Department of Medical Sciences, Ferrara, Italy PubMed articles Google scholar articles
S De Vita 7University Hospital “Santa Maria della Misericordia”, Clinic of Rheumatology- DSMB, Udine, Italy PubMed articles Google scholar articles
R De Angelis 8University of Jesi, Rheumatology Department, Jesi, Italy PubMed articles Google scholar articles
C Salvarani 9Azienda Ospedaliera-IRCCS di Reggio Emilia, Rheumatology Unit- Department of Internal Medicine, Reggio Emilia, Italy PubMed articles Google scholar articles
R Gerli 10University of Perugia, Rheumatology Unit- Department of Medicine, Perugia, Italy PubMed articles Google scholar articles
A Tincani 11ASST Spedali Civili- University of Brescia, Rheumatology and Clinical Immunology Unit, Brescia, Italy PubMed articles Google scholar articles
A Doria 1Università degli Studi di Padova – Azienda Ospedaliera, Department of Medicine-DIMED- Division of Rheumatology, Padova, Italy PubMed articles Google scholar articles

Citation

Larosa M, Iaccarino L, Zen M, et al

95 Efficacy, damage accrual and predictors of response to belimumab in active sle patients: a large italian multicenter prospective study

Lupus Science & Medicine 2017;4:doi: 10.1136/lupus-2017-000215.95

Publication history

First published March 24, 2017.

Online issue publication

March 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password